Aussie Court OKs Myriad Gene Patents, Knocks US High Court
An Australian appeals court ruled Friday that Myriad Genetics Inc.'s patents on isolated genes associated with a risk of breast cancer are patent-eligible, and criticized the U.S. Supreme Court, which it...To view the full article, register now.
Already a subscriber? Click here to view full article